Literature DB >> 20009880

CYP1A1 and CYP2D6 gene polymorphisms in Israeli Jewish women with cervical cancer.

Guy Gutman1, Tova Morad, Ben Peleg, Chavah Peretz, Amiram Bar-Am, Tamar Safra, Dan Grisaru.   

Abstract

HYPOTHESIS: To assess the frequency distribution of the CYP1A1 and CYP2D6 gene polymorphisms in Israeli Jewish women with cervical cancer.
METHODS: Forty-three Israeli Jewish women with cervical cancer and 123 healthy Israeli Jewish women were assessed. CYP1A1 (2 alleles) and CYP2D6 polymorphism was analyzed using an allele-specific, polymerase chain reaction-based method.
RESULTS: The allele frequency and genotype distribution for the CYP1A1 (2 alleles) and CYP2D6 polymorphism did not reach a level of significance. Smoking was the only independent risk factor for cervical cancer (P = 0.0003).
CONCLUSION: CYP1A1 and CYP2D6 mutations are not related to an increased risk for cervical cancer in the Jewish Israeli population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009880     DOI: 10.1111/IGC.0b013e3181b9fa5d

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

Review 1.  Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.

Authors:  Liangbin Xia; Jing Gao; Yan Liu; Ke Wu
Journal:  Tumour Biol       Date:  2012-10-04

2.  Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: a meta-analysis.

Authors:  Theodoros N Sergentanis; Konstantinos P Economopoulos; Souzana Choussein; Nikos F Vlahos
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

3.  CYP2D6*3 (A2549del), *4 (G1846A), *10 (C100T) and *17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen.

Authors:  Fatemeh Saghafi; Ebrahim Salehifar; Ghasem Janbabai; Ehsan Zaboli; Akbar Hedayatizadeh-Omran; Omolbanin Amjadi; Siavash Moradi
Journal:  Biomed Rep       Date:  2018-09-07

4.  CYP1A1 Ile462Val polymorphism and cervical cancer: evidence from a meta-analysis.

Authors:  Shuyan Yang; Changru Jia; Hong Zhu; Shiyu Han
Journal:  Tumour Biol       Date:  2012-09-05

5.  MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis.

Authors:  Bin Wu; Kang Liu; Huaxing Huang; Jun Yuan; Wanqing Yuan; Shangqian Wang; Tingting Chen; Hu Zhao; Changjun Yin
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

6.  CYP1A1 Ile462Val Polymorphism Is Associated with Cervical Cancer Risk in Caucasians Not Asians: A Meta-Analysis.

Authors:  Li-Na Wang; Fen Wang; Jie Liu; Ying-Hui Jin; Cheng Fang; Xue-Qun Ren
Journal:  Front Physiol       Date:  2017-12-18       Impact factor: 4.566

7.  Genetic Polymorphisms of the Human Cytochrome P450 1A1 (CYP1A1) and Cervical Cancer Susceptibility among Northeast Thai Women.

Authors:  Mayuree Wongpratate; Wannapa Ishida; Sophida Phuthong; Sitakan Natphopsuk; Takafumi Ishida
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01

8.  CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish population.

Authors:  Andrzej Roszak; Margarita Lianeri; Anna Sowińska; Pawel P Jagodziński
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

Review 9.  Pleiotropic Functions of Cytochrome P450 Monooxygenase-Derived Eicosanoids in Cancer.

Authors:  Ying Luo; Jun-Yan Liu
Journal:  Front Pharmacol       Date:  2020-10-29       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.